Neil Chatterji
Stock Analyst at B. Riley Securities
(1.40)
# 3,438
Out of 4,896 analysts
19
Total ratings
23.53%
Success rate
0.25%
Average return
Main Sectors:
Stocks Rated by Neil Chatterji
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLPT ClearPoint Neuro | Maintains: Buy | $20 → $28 | $11.40 | +145.61% | 4 | Apr 25, 2025 | |
| OPRX OptimizeRx | Maintains: Buy | $17 → $13 | $12.70 | +2.36% | 3 | Dec 24, 2024 | |
| ESTA Establishment Labs Holdings | Maintains: Buy | $95 → $50 | $44.89 | +11.38% | 2 | Nov 9, 2023 | |
| ARAY Accuray | Reiterates: Buy | $7.5 | $1.36 | +451.47% | 1 | Oct 4, 2023 | |
| ZUMZ Zumiez | Maintains: Neutral | $15 → $18 | $13.28 | +35.54% | 2 | Sep 8, 2023 | |
| KRMD KORU Medical Systems | Initiates: Buy | $4.5 | $3.48 | +29.31% | 1 | Sep 7, 2023 | |
| HYPR Hyperfine | Maintains: Buy | $2.5 → $3.5 | $0.77 | +355.14% | 3 | Aug 15, 2023 | |
| STXS Stereotaxis | Maintains: Buy | $6 → $5.5 | $2.25 | +144.44% | 2 | Mar 6, 2023 | |
| BFLY Butterfly Network | Initiates: Buy | $9.5 | $1.81 | +424.86% | 1 | Oct 4, 2022 |
ClearPoint Neuro
Apr 25, 2025
Maintains: Buy
Price Target: $20 → $28
Current: $11.40
Upside: +145.61%
OptimizeRx
Dec 24, 2024
Maintains: Buy
Price Target: $17 → $13
Current: $12.70
Upside: +2.36%
Establishment Labs Holdings
Nov 9, 2023
Maintains: Buy
Price Target: $95 → $50
Current: $44.89
Upside: +11.38%
Accuray
Oct 4, 2023
Reiterates: Buy
Price Target: $7.5
Current: $1.36
Upside: +451.47%
Zumiez
Sep 8, 2023
Maintains: Neutral
Price Target: $15 → $18
Current: $13.28
Upside: +35.54%
KORU Medical Systems
Sep 7, 2023
Initiates: Buy
Price Target: $4.5
Current: $3.48
Upside: +29.31%
Hyperfine
Aug 15, 2023
Maintains: Buy
Price Target: $2.5 → $3.5
Current: $0.77
Upside: +355.14%
Stereotaxis
Mar 6, 2023
Maintains: Buy
Price Target: $6 → $5.5
Current: $2.25
Upside: +144.44%
Butterfly Network
Oct 4, 2022
Initiates: Buy
Price Target: $9.5
Current: $1.81
Upside: +424.86%